Stock IdeasStrong Buy StocksStrong Buy Stocks from Top Wall Street AnalystsLatest stocks with a Strong Buy rating from the top performing 25% of analysts tracked by WallStreetZen
Stock IdeasStrong Buy Stocks
| Analyst / Firm | Company | Price | Rating | Price Target | Upside/Downside | Date |
|---|---|---|---|---|---|---|
Pharming Group NvPHAR | $12.13 | Strong Buy | $41.00 | +238.00% | 17 hours ago | |
Analyst RankingTop 8% #394 out of 5549 analysts Average Return+18.21% Win Rate45%69 out of 154 Risk vs RewardPoor Good Analyst ColorCanaccord Genuity's Whitney Ijem raised their price target on Pharming Group Nv (NASDAQ: PHAR) by 7.9% from $38 to $41 on 2026/10/30. The analyst maintained their Strong Buy rating on the stock. Pharming Group NV reported its Q3 2026 earnings. Following last week's pre-announcement, the company delivered its full Q3 2026 results, which represented incremental upside, Whitney told readers.
| ||||||
Tesla IncTSLA | $800.00 | Strong Buy | $850.00 | +6.25% | a day ago | |
Upgrade to Premium to View MoreStrong buys: Upgrade to Premium to view the rest of today's Strong Buy stocks from Wall Street's top analysts Already have access to Premium? Sign In | ||||||
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.